Rallybio Quote - RLYB

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

1.39

Bid

1.34

Offer

1.42

Volume

66,372

1.3301 Day's Range 1.38

1.155 52 Week Range 6.33

Market Cap

57.615M

Previous Close

1.33

Open

1.36

Last Trade

1.37

Last Trade Time

09:30:03

Financial Volume

US$ 89,541

VWAP

1.3491

Average Volume (3m)

173,503

Shares Outstanding

41,449,297

Dividend Yield

PE Ratio

-0.75

Earnings Per Share (EPS)

-1.8

Revenue

Net Profit

-74.56M

Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening ... Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.rallybio.com.

Headquarters

Wilmington, Delaware, USA

Founded

1970

Rallybio Holdings LLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RLYB. The last closing price for Rallybio was US$1.33. Over the last year, Rallybio shares have traded in a share price range of US$ 1.155 to US$ 6.33.

Rallybio currently has 41,449,297 shares in issue. The market capitalisation of Rallybio is US$55.13 million. Rallybio has a price to earnings ratio (PE ratio) of -0.75.

Form 8-K - Current report

Rallybio to Present at the 2024 Jones Healthcare Seaside Summit

Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today...

Rallybio Announces Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations

– First Reported Large-Scale Analysis of FNAIT Risk Across Broad Population of Diverse Ancestries – – Topline Results Suggest a Significant Increase in the Number of Pregnancies at Higher Risk...

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.08	6.10687022901	1.31	1.38	1.29	51190	1.32205636	CS
4	0.01	0.724637681159	1.38	1.49	1.155	130271	1.30164664	CS
12	-0.48	-25.6684491979	1.87	2	1.155	173503	1.550978	CS
26	-0.02	-1.41843971631	1.41	3.46	1.155	907352	2.61839384	CS
52	-4.54	-76.5598650927	5.93	6.33	1.155	497779	2.6366345	CS
156	-13.53	-90.6836461126	14.92	25.78	1.155	228247	4.62203142	CS
260	-13.53	-90.6836461126	14.92	25.78	1.155	228247	4.62203142	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
VPRVolt Group Ltd	AUD 0.002 (100.00%)	12.5k
KNBOKoonenberry gold Ltd	AUD 0.004 (100.00%)	260.57k
WOAOWide Open Agriculture Ltd	AUD 0.003 (50.00%)	1M
MCTMetalicity Ltd	AUD 0.003 (50.00%)	1.33M
INDIndustrial Minerals Limited	AUD 0.255 (41.67%)	151.45k
ESROBEstrella Resources Limited	AUD 0.001 (-50.00%)	2M
FG1OFlynn Gold Limited	AUD 0.004 (-42.86%)	2.02M
OVTOvanti Ltd	AUD 0.003 (-40.00%)	6.24M
CPOOCulpeo Minerals Ltd	AUD 0.008 (-33.33%)	400k
IMIInfinity Mining Ltd	AUD 0.01 (-28.57%)	232.1k
BGLBellevue Gold Limited	AUD 1.45 (-20.98%)	80.17M
E79E79 Gold Mines Ltd	AUD 0.041 (20.59%)	56.75M
AGYArgosy Minerals Inc	AUD 0.049 (40.00%)	53.8M
JRVJervois Global Ltd	AUD 0.016 (6.67%)	42.87M
REDRed 5 Limited	AUD 0.375 (-5.06%)	36.66M